Introduction {#cwx019s1}
============

Glycosylation as the most frequent modification of proteins ([@cwx019C29]; [@cwx019C33]; [@cwx019C61]; [@cwx019C6]; [@cwx019C32]; [@cwx019C30]; [@cwx019C59]; [@cwx019C43]) is well known to modify protein properties, endowing them with a wide repertoire of glycan-mediated functions. These can be as diverse as enabling site-directed delivery of glycoconjugates as well as mediating signaling events and modulating cell adhesion processes ([@cwx019C60]; [@cwx019C56]). In the context of bacterial physiology, glycosylation can trigger the colonization of a specific host (region). Due to the increasing discovery of glycoconjugates in pathogenic bacteria, their investigation in a biomedical context is of great relevance. Especially, bacterial cell surface glycans, which represent the immediate contact zone of bacteria with the environment/host, seem to be prone to act as specific ligands for cell--cell or cell--bacterium interactions, or to serve as virulence factors based on molecular mimicry of host glycans ([@cwx019C63]).

Nonulosonic acids are particularly important at the interface of bacterial pathogenicity and human physiology ([@cwx019C62]; [@cwx019C31]). They share a nine-carbon carbohydrate monomer as a common core structure, with additional structural variations mostly occurring at the C-5 and C-7 leading to over 50 derivatives identified so far across archaea, bacteria and eukaryotes ([@cwx019C1]; [@cwx019C20]). Sialic acid (Sia; neuraminic acid-Neu5Ac) carrying an *N*-acetyl group at the C-5 are the most abundant naturally occurring and best studied nonulosonic acids. Two exclusively bacterial derivatives, present in pathogens, are pseudaminic acid (5,7-diacetamido-3,5,7,9-tetradeoxy-[l]{.smallcaps}-*glycero*-α-[l]{.smallcaps}-*manno*-non-2-ulopyranosonic acid; Pse) and legionaminic acid (5,7-diacetamido-3,5,7,9-tetradeoxy-[d]{.smallcaps}-*glycero*-[d]{.smallcaps}-*galacto*-non-2-ulopyranosonic acid; Leg) ([@cwx019C71]). The exact biological roles of pseudaminic acid and legionaminic acid and their derivatives are not yet fully understood. The modification of flagellins with these nonulosonic acids in *Campylobacter* and *Helicobacter* species confers bacterial virulence in facilitating bacterial host interactions ([@cwx019C57]; [@cwx019C44]). In two *Campylobacter jejuni* strains, the modification of flagellin subunits with Pse5Ac7Ac was found to be necessary for the assembly of a functional flagellum and, consequently, bacterial motility ([@cwx019C12]). Further, the structural similarity of pseudaminic acid and legionaminic acid to eukaryotic sialic acid indicates molecular mimicry as a basic strategy these pathogens may employ to evade the host immune response ([@cwx019C20]; [@cwx019C67]). However, it should be noted here that Pse and Leg have different stereochemistry, making Leg a potentially better mimic of host neuraminic acids than Pse.

The complete five-step biosynthesis pathway of cytidine monophosphate-activated pseudaminic acid (CMP-Pse) representing the biologically active form of pseudaminic acid for its incorporation into glycoconjugates has been characterized in detail in *Helicobacter pylori* ([@cwx019C45]), the pathway leading to CMP-Leg has been elucidated in *C. jejuni* ([@cwx019C46]). However, the subsequent and necessary transfer step of the nonulosonic acid from its nucleotide activator onto the acceptor---which might be the glycosylation site on a target polypeptide or a sugar residue within an oligosaccharide---by a dedicated nonulosonic acid transferase remains elusive. So far, the only report of a candidate pseudaminic acid transferase found in the literature concerns the motility-associated factor Maf1 predicted to be involved in the transfer of pseudaminic acid onto the flagellin of *Aeromonas caviae* ([@cwx019C36]). This was concluded from pull-down experiments between Maf1 and the flagellin, without provision of direct evidence of enzymatic function ([@cwx019C37]). With regard to legionaminic acid transferases, no predictions of such enzymes are presently available, neither in the literature nor in databases. Interestingly, selected sialyltransferases, i.e., porcine ST3Gal1, *Pasteurella multocida* sialyltransferase, *Photobacterium* α2,6-sialyltransferase and *Neisseria meningitidis* MC58 α2,3-sialyltransferase, were shown to accept CMP-Leg5Ac7Ac as a donor substrate to replace Sia as terminal sugar ([@cwx019C68], [@cwx019C69]).

*Tannerella forsythia* provides the unique situation of a bacterium that strain-specifically displays either a pseudaminic or a legionaminic acid derivative as terminal sugar on an otherwise structurally very similar, protein-bound oligosaccharide ([@cwx019C38]; [@cwx019C10]). *Tannerella forsythia* is a Gram-negative bacterium that is recognized as a key periodontal pathogen ([@cwx019C50]; [@cwx019C15]) following the polymicrobial synergy and dysbiosis model of periodontal disease etiology ([@cwx019C14]; [@cwx019C13]). The molecular basis of its pathogenicity is only slowly unraveling. Among several identified virulence factors ([@cwx019C66]; [@cwx019C49]), such as the outer membrane protein BspA ([@cwx019C34]), KLIKK-proteases ([@cwx019C21]) and outer membrane vesicles ([@cwx019C9]; [@cwx019C65]), are the two glycosylated cell surface (S-) layer proteins TfsA and TfsB which self-assemble into a 2D crystalline array on the bacterial cell surface, completely covering the outer membrane ([@cwx019C41]; [@cwx019C47]; [@cwx019C40]). We have shown for the *T. forsythia* ATCC 43037 type strain that the S-layer proteins as well as several other cell surface and outer membrane proteins of *T. forsythia* are modified at multiple sites at the conserved D(S/T)(A/I/L/V/M/T) motif with the same *O*-linked dekasaccharide ([@cwx019C7]; [@cwx019C38]), which displays a pseudaminic acid with an acetamidino (Am) group at C-5 and a glyceric acid at C-7 (Gra)---Pse5Am7Gra---as terminal, nonreducing end residue.

The biosynthesis of CMP-Pse in *T. forsythia* ATCC 43037 was only recently shown to be encoded by a dedicated gene locus ([@cwx019C10]) present in immediate vicinity to the general protein *O*-glycosylation gene cluster of *T. forsythia* ATCC 43037 ([@cwx019C38]). In fact, we expressed and confirmed the activity of all five necessary enzymes from the CMP-Pse biosynthetic pathway in that strain ([@cwx019C10]), which proceeds in analogy to what has been described for *H. pylori* ([@cwx019C45]). Since candidates for the enzymes modifying the pseudaminic acid in *T. forsythia* ATCC 43037 have not been identified so far, a crucial point still to be answered concerns the biosynthetic stage at which the modifications are transferred onto the nonulosonic acid.

On the genome of *T. forsythia* UB4 (Genbank accession number FMMN00000000; [@cwx019C52]), the genes encoding the biosynthetic enzymes for CMP-Leg are replacing those for CMP-Pse in strain ATCC 43037. This was confirmed in step-wise in vitro assays using the recombinant enzymes ([@cwx019C10]), based on the knowledge of the CMP-Leg biosynthetic pathway in *C. jejuni* ([@cwx019C46]). In terms of basic sugar composition and glycan structure, the *O-*glycan of strain UB4 was found to be identical to that of strain ATCC 43037 ([@cwx019C38]) apart from a mass defect of 29 Da on the terminal Leg residue, likely reflecting different noncarbohydrate substituents as compared to the Gra and Am modifications of the ATCC 43037 pseudaminic acid residue, as well as a missing methyl group on the proximal *N*-acetylmannosaminuronic acid residue (−14 Da) ([@cwx019C10]).

Considering that the *T. forsythia* S-layer is classified as a virulence factor ([@cwx019C49]), it might well be that the involvement of the S-layer in the cell adhesion and invasion capability of the bacterium ([@cwx019C42]) as well as in the delay of the host immune response against the bacterium ([@cwx019C16]; [@cwx019C47]) is impacted by the bacterium\'s nonulosonic acids.

In this study, we investigated a putative pseudaminic acid derivative transferase (Tanf_01245) from the oral pathogen *T. forsythia* ATCC 43037 and a putative legionaminic acid derivative transferase (TFUB4_00887) from the clinical isolate *T. forsythia* UB4, using the abundant *T. forsythia* S-layer glycoproteins as a model system ([@cwx019C38]). Specifically, this included (i) construction of *T. forsythia* deletion mutants targeted at the candidate nonulosonic acid derivative transferases and subsequent determination of the effect of the gene deletion on S-layer *O*-glycan composition by mass spectrometry; (ii) analysis of the mutants for their cellular pool of nucleotide-activated sugars in order to exclude interference of the candidate transferases with the biosynthetic pathways of the nonulosonic acid precursor and to unravel if the nonulosonic acid modifications are present already at the CMP-bound state and (iii) a cross-complementation experiment of the nonulosonic acid derivative transferase mutants with the nonnative *T. forsythia* enzyme to learn about the specificity of the enzymes, considering that the core structures of pseudaminic acid and legionaminic acid are stereoisomers and that these residues would be transferred onto the same sugar acceptor residue within the S-layer *O*-glycan structure.

This is the first report on plausible enzyme candidates for the transfer of a pseudaminic acid (Pse5Am7Gra) and a legionaminic acid derivative as a terminal residue onto a glycoprotein glycan.

Results {#cwx019s2}
=======

Bioinformatic analyses of candidate genes for the transfer of nonulosonic acids in *T. forsythia* {#cwx019s2a}
-------------------------------------------------------------------------------------------------

Recent findings from our laboratory revealed the presence of a functional biosynthetic pathway for either CMP-Pse or CMP-Leg in different *T. forsythia* strains (ATCC 43037, UB4 and 92A2, respectively) ([@cwx019C10]), elaborated in the course of the general *T. forsythia* protein *O*-glycosylation system (Markus Tomek, Valentin Friedrich, Christina Schäffer, unpublished data). To investigate the subsequent transfer step of the activated nonulosonic acid derivative on a proximal *N*-acetylmannosaminuronic acid residue as present in *T. forsythia* protein *O*-glycans, we were focusing here on two genes encoding putative nonulosonic acid derivative transferases. The candidate Pse derivative transferase gene *Tanf_01245* is located immediately down-stream of the CMP-Pse biosynthesis locus on the *T. forsythia* ATCC 43037 genome and the candidate Legderivative transferase gene *TFUB4_00887* is found on the *T. forsythia* UB4 genome down-stream of the CMP-Leg biosynthesis gene locus, separated only by a putative methyltransferase ([@cwx019C10]). The predicted transferases Tanf_01245 (445 amino acids; calculated molecular weight, 51.9 kDa) and TFUB4_00887 (442 amino acids; calculated molecular weight, 51.3 kDa) share 81% amino acid sequence identity. Precisely, the sequences of the 241-amino acid long C-terminal domains are identical in both proteins (Figure [1](#cwx019F1){ref-type="fig"}A). A DXD motif starting at position D205 (strain ATCC 43037) and D202 (strain UB4), respectively, is present at the beginning of the conserved C-terminal domain (Figure [1](#cwx019F1){ref-type="fig"}A). This short motif is found in many families of glycosyltransferases (GTs), which add a range of different sugars to other sugars, phosphates and proteins. All DXD-containing GTs use nucleoside diphosphate sugars as donors and require divalent cations, typically manganese ([@cwx019C2]). Usually, however, DXD-motifs are absent in sialyltransferases ([@cwx019C3]), which do not require divalent metal ions for enzymatic activity. Two recently identified functional motifs (D/E-D/E-G and HP), found in *N. meningitidis* (*Nm*B-polyST) and *P. multocida* (*Pm*ST1), are highly conserved in bacterial sialyltransferases and important to enzyme catalysis and CMP-Neu5Ac binding ([@cwx019C8]). Both motifs are present in the putative nonulosonic acid transferases studied here (Figure [1](#cwx019F1){ref-type="fig"}A). Further bioinformatic analyses (Basic Local Alignment Search Tool---BLAST at <http://blast.ncbi.nlm.nih.gov/Blast.cgi>) suggested a GT B-type superfamily domain using NCBI\'s conserved domain database (CDD) (<https://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi>, version CDD v3.15) or a putative conserved TagB superfamily domain (version CDD v3.14) ([@cwx019C28]), spanning the same amino acid residues, to be present in both proteins (Figure [1](#cwx019F1){ref-type="fig"}B). The TagB protein has been implicated in the priming step of poly(glycerol phosphate) wall teichoic acid synthesis in *Bacillus subtilis* ([@cwx019C54]). There, TagB adds a single glycerol phosphate residue to the nonreducing end of undekaprenyl-phosphate-linked *N*-acetylmannosamine-β(1,4)-*N*-acetylglucosamine-1-phosphate, which reveals analogy in basic sugar structure with the *N*-acetylmannosaminuronic acid residue present as acceptor in the *T. forsythia O*-glycan. Secondary structure predictions performed at <http://bioinf.sce.carleton.ca/PCISS/start.php> indicate for *T. forsythia* ATCC 43037 Tanf_01245 and *T. forsythia* UB4 TFUB4_00887, an α-helix content of 34.38% and 32.58%, a β-sheet content of 20.90% and 22.40%, respectively, and 45% turns, each. No transmembrane regions are predicted for the nonulosonic acid derivative transferases using the prediction server TMHMM 2.0 (<http://www.cbs.dtu.dk/services/TMHMM/>). Fig. 1.Bioinformatic and molecular phylogenetic analyses of putative nonulosonic acid derivative transferases from different *T. forsythia* strains. (**A**) Amino acid sequence alignment of Tanf_01245 (strain ATCC 43037), TFUB4_00887 (strain UB4), TFUB20_01003 (strain UB20), BFO_1060 (strain FDC 92A2), TFKS16_1100 (strain KS16), TFUB22_00887 (strain UB22) and TF3313_0988 (strain 3313) illustrates a high sequence identity (81%) for all compared sequences except for that from strain 3313, and conservation of the C-terminal domain. Conserved motifs (DXD, D/E-D/E-G and HP) are indicated within boxes (alignment was done with the software Multalin at <http://multalin.toulouse.inra.fr>). (**B**) A conserved TagB superfamily domain (version CDD v3.14) or a GT B-type (version CDD v3.15) superfamily domain was identified in all candidate nonulosonic acid transferases using the NCBI\'s CDD (<https://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi>) ([@cwx019C28]). (**C**) The evolutionary history of nonulosonic acid transferases from different *T. forsythia* strains was inferred by using the Maximum Likelihood method based on the JTT matrix-based model ([@cwx019C18]). Four investigated strains (FDC 92A2, KS16, UB22 and UB4) have identical amino acid sequences and group together in the phylogenetic tree, thus representing strains with legionaminic acid transferases, while two strains, including the ATCC type strain (ATCC 43037) and strain UB20 are representing strains with pseudaminic acid transferases. Interestingly, strain 3313 does not group in neither of the nonulosonic acid transferases and thus has an unknown GT activity. The tree is drawn to scale, with branch lengths measured in the number of substitutions per site. Evolutionary analyses were conducted in MEGA7 ([@cwx019C22]). This figure is available in black and white in print and in color at *Glycobiology* online.

To obtain insight in the prevalence of the predicted nonulosonic acid derivative transferases in *T. forsythia* strains, we included in the multiple sequence alignment further sequences of homologous proteins from other publically available genomes of *T. forsythia* strains, including Tanf_01245 (strain ATCC 43037), TFUB4_00887 (strain UB4), TFUB20_01003 (strain UB20), BFO_1060 (strain FDC 92A2), TFKS16_1100 (strain KS16), TFUB22_00887 (strain UB22) and TF3313_0988 (strain 3313), revealing 246 identical C-terminal amino acid residues in all compared sequences. Based on differences at the amino acid level in the N-terminal regions, all aligned proteins except TF3313_0988 matched either the Tanf_01245 sequence from strain ATCC 43037 or the TFUB4_00887 sequence from strain UB4 (Figure [1](#cwx019F1){ref-type="fig"}A). This result is also reflected by analyzing the phylogenetic relationship of nonulosonic acid transferases ([@cwx019C18]; [@cwx019C22]) (Figure [1](#cwx019F1){ref-type="fig"}C).

The migration behavior of S-layer glycoproteins on sodium dodecyl sulfate-polyacrylamide gel electrophoresis is affected by knocking-out the putative Pse and Leg derivative transferases {#cwx019s2b}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The glycosylated S-layer proteins TfsA and TfsB are the most abundant and best characterized glycoproteins in *T. forsythia* strains ([@cwx019C38]; [@cwx019C48]) and, thus, were chosen as model glycoproteins for investigating the putative nonulosonic acid derivative transferases.

To assess an overall involvement of Tanf_01245 (candidate Pse derivative transferase) and TFUB4_00887 (candidate Leg derivative transferase) in S-layer protein glycosylation, the sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) pattern of the respective gene deletion mutants *T. forsythia* ATCC 43037 Δ*Tanf_01245* and *T. forsythia* UB4 Δ*TFUB4_00887* was compared to that of the corresponding parent strains and the reconstituted strains (*T. forsythia* ATCC 43037 Δ*Tanf_01245*^*+*^ and *T. forsythia* UB4 *TFUB4_00887*^*+*^). Upon protein staining of crude cell extracts with Coomassie Brilliant Blue (CBB) (Figure [2](#cwx019F2){ref-type="fig"}A), the S-layer glycoproteins of both strain ATCC 43037 and UB4 appeared as prominent high-molecular mass bands, with TfsA migrating at \~230 kDa (calculated MW, 135 kDa) and TfsB at \~270 kDa (calculated MW, 152 kDa), as expected ([@cwx019C38]). A clear down-shift of both S-layer glycoproteins (\~20 kDa, each) was visible in ATCC 43037 Δ*Tanf_01245*, and the native migration behavior could be restored in the reconstituted strain ATCC 43037 Δ*Tanf_01245*^*+*^ (Figure [2](#cwx019F2){ref-type="fig"}A). The same result was obtained in an analogous experiment performed with *T. forsythia* UB4, where the parent strain, UB4 Δ*TFUB4_00887* and the reconstituted strain were compared (Figure [2](#cwx019F2){ref-type="fig"}A). Western immunoblots using polyclonal antibodies directed against the S-layer proteins TfsA (Figure [2](#cwx019F2){ref-type="fig"}B) and TfsB (Figure [2](#cwx019F2){ref-type="fig"}C) confirmed the identity of the said proteins in either *T. forsythia* strain, and simultaneously pinpointed a role of Tanf_01245 and TFUB4_00887 in the general protein *O*-glycosylation pathway of ATCC 43037 and UB4, respectively. Fig. 2.SDS-PAGE and Western immunoblot analyses of *T. forsythia* ATCC 43037 and *T. forsythia* UB4 wild-type and mutants. (**A**) CBB staining of crude cell extracts from *T. forsythia* ATCC 43037 wild-type, Δ*Tanf_01245* mutant, reconstituted mutant Δ*Tanf_01245*^+^ and cross-complemented mutant Δ*Tanf_01245*^+*TFUB4_00887*^ after separation on a 7.5% SDS-PA gel. The S-layer glycoproteins (labeled TfsA and TfsB) are indicated and the down-shift resulting from the loss of the Pse5Am7Gra residue can be observed in the deletion mutant and in the cross-complemented mutant, while in the reconstituted strain the bands are up-shifted again to wild-type level. The same migration profiles could be observed for *T. forsythia* UB4 wild-type, Δ*TFUB4_00887* mutant, reconstituted mutant Δ*TFUB4_00887*^+^ and cross-complemented mutant Δ*TFUB4_00887*^+*Tanf_01245*^. PageRuler Plus Prestained Protein Ladder (Thermo Fisher Scientific) was used as a protein molecular weight marker. The S-layer glycoprotein bands were further processed for MS analyses. Western immunoblots probed with anti-TfsA antiserum (**B**) and anti-TfsB antiserum (**C**) confirmed the identity of the S-layer glycoproteins in all analyzed *T. forsythia* species. PageRuler Prestained Protein Ladder (Thermo Fisher Scientific) was used as a molecular weight marker.

*O*-Glycans of *T. forsythia* Pse and Leg derivative transferase knock-out mutants are devoid of the terminal nonulosonic acid {#cwx019s0022}
------------------------------------------------------------------------------------------------------------------------------

Knocking-out *Tanf_01245* resulted in a loss of the terminal Pse5Am7Gra residue on the *O*-glycans of *T. forsythia* ATCC 43037 as revealed by electrospray ionization ion-trap mass spectrometry (ESI-IT-MS) analyses of β-eliminated S-layer glycans. Deconvoluted mass spectra showed the highest mass peak at *m*/*z* = 1523.4 \[M + H\]^+^, which conforms with the *m*/*z* value of the *T. forsythia O*-glycan lacking the Pse5Am7Gra residue (361.2 Da) and, additionally, one methyl group (14.0 Da); the latter was determined to be missing at the branching *N*-acetylmannosaminuronic acid residue (Figure [3](#cwx019F3){ref-type="fig"}A). Additional peaks with a typical fragmentation pattern of a glycan moiety were assigned and showed the subsequent loss of sugar residues and side chain modifications of the mutant *O*-glycan. The doubly charged complete wild-type *O*-glycan exhibited an *m*/*z* signal of 949.9 \[M + 2 H\]^2+^, which corresponds to *m*/*z* = 1898.8 when calculating a singly charged form thereof. In the reconstituted strain ATCC 43037 Δ*Tanf_01245*^+^, Pse5Am7Gra transfer could be fully restored, as evidenced by the detection of a glycan with *m*/*z* = 949.7 \[M + 2 H\]^2+^, which corresponds to the mass of the wild-type glycan (Figure [3](#cwx019F3){ref-type="fig"}A). Fig. 3.Deconvoluted ESI-IT-MS sum spectra of β-eliminated TfsB *O*-glycans from *T. forsythia* parent and mutant strains. (**A**) Comparison of the spectra from *T. forsythia* ATCC 43037 wild-type, Δ*Tanf_01245* mutant, reconstituted mutant Δ*Tanf_01245*^+^ and cross-complemented mutant Δ*Tanf_01245*^+*TFUB4_00887*^. (**B**) Comparison of the spectra from *T. forsythia* UB4 wild-type, Δ*TFUB4_00887* mutant, reconstituted mutant Δ*TFUB4_00887*^+^ and cross-complemented mutant Δ*TFUB4_00887*^+*Tanf_01245*^. Another glycan species with additional +16 Da at the position of the digitoxose was observed, indicative of the presence of a deoxyhexose instead of a dideoxyhexose in some forms of the glycan. The glycan structures of the highest mass peaks are shown as symbolic representations. Mass peaks from the subsequent fragmentation pattern were assigned according to the loss of carbohydrate units and modifications. Relative peak intensities of occurring peaks are given on the *y* axis. This figure is available in black and white in print and in color at *Glycobiology* online.

The wild-type *O*-glycan of *T. forsythia* UB4, where the Pse derivative is replaced by a Leg residue with calculated acetyl (Ac) and glycolyl (Gc) modifications ([@cwx019C10]), exhibits *m*/*z* = 936.8 \[M + 2 H\]^2+^, which corresponds to an *m*/*z* = 1872.6 of the \[M + H\]^+^ ion. In the UB4 Δ*TFUB4_00887* mutant, the Leg derivative (350.2 Da) as well as one methyl group (−14.0 Da) modifying the *N*-acetylmannosaminuronic acid residue was no longer present as evidenced by the prominent peak with *m*/*z* = 1523.4 \[M + H\]^+^ (Figure [3](#cwx019F3){ref-type="fig"}B). As reported recently ([@cwx019C10]), also in this analysis, both in the UB4 wild-type and the UB4 Δ*TFUB4_00887* mutant another glycan species with additional +16 Da at the position of the digitoxose could be observed, indicating the presence of a deoxyhexose instead of a dideoxyhexose in some forms of the glycan. Still, in the reconstituted strain *T. forsythia* UB4 Δ*TFUB4_00887*^*+*^, the production of the Leg derivative was fully restored, resulting in *m*/*z* = 936.8 \[M + 2 H\]^2+^, which conforms with that of the *T. forsythia* UB4 wild-type glycan (Figure [3](#cwx019F3){ref-type="fig"}B).

These data corroborated the involvement of Tanf_01245 and TFUB4_00887 in the transfer of the Pse and Leg derivative, respectively, during *T. forsythia O*-glycan assembly. Furthermore, it is indicated that methylation of the branching *N*-acetylmannosaminuronic acid residue occurs only after transfer of the respective nonulosonic acid derivative to the other, terminal *N*-acetylmannosaminuronic acid residue of *T. forsythia* ATCC 43037 *O*-glycan.

CMP activation and modification of nonulosonic acids occur prior to their transfer onto the *O*-glycan {#cwx019s2c}
------------------------------------------------------------------------------------------------------

Considering that the nonulosonic acids present in the *T. forsythia O*-glycans carry modifications, i.e., the proven Am (at C-5) and Gra (at C-7) modifications of the Pse residue in ATCC 43037 and the calculated Ac and Gc modifications (based on mass spectrometry (MS) data) of the Leg residue in UB4 ([@cwx019C38]; [@cwx019C10]) and that the modifying enzymes are still unknown, we wanted to rule out that the candidate transferases (Tanf_01245 and TFUB4_00887) would be involved in the modification instead of the predicted transfer process, which would also result in a loss of the nonulosonic acid on the *O*-glycans if the modifications were a prerequisite for the transfer to occur. Thus, the cellular pool of nucleotide-activated sugars was analyzed for the *T. forsythia* ATCC 43037 Δ*Tanf_01245* and *T. forsythia* UB4 Δ*TFUB4_00887* mutants and compared to that of the parent strains. Besides known uridine 5′-diphosphate (UDP)- and guanosine-5′-diphosphate (GDP)-activated sugars, CMP-Pse5Am7Gra with *m*/*z =* 683.2 ([@cwx019C38]) representing the fully modified Pse precursor was clearly visible in the pool of nucleotide-activated sugars prepared from cell extracts of both the ATCC 43037 wild-type and the ATCC 43037 Δ*Tanf_01245* mutant (Figure [4](#cwx019F4){ref-type="fig"}A). As a negative control, the ATCC 43037 Δ*pseC* mutant available from a recent study ([@cwx019C10]), where the *m*/*z =* 683.2 compound is missing as a result of abolishing Pse biosynthesis, was used (Figure [4](#cwx019F4){ref-type="fig"}A), confirming the validity of the analysis. Fig. 4.ESI-IT-MS analysis of cellular nucleotide sugar pools from *T. forsythia* strains. (**A**) CMP-activated Pse5Am7Gra (*m*/*z* 683.3) was detected in the *T. forsythia* ATCC 43037 wild-type and in the Δ*Tanf_01245* mutant, whereas this mass was absent in a Pse biosynthesis deficient strain (Δ*pseC*) which served as a negative control. (**B**) In *T. forsythia* UB4 wild-type and in the Δ*TFUB4_00887* mutant, a *m*/*z* 654.3 peak was identified, which was attributed to a CMP-activated Leg derivative (CMP-Leg\*). This mass is consistent with having Ac and Gc modifications on Leg, based on calculation. Notably, this peak was absent in the Legbiosynthesis deficient strain (Δ*legC*) which served as a negative control. Relative peak intensities are given on the *y* axis.

Legionaminic acid modification prior to transfer to the *O*-glycan was confirmed for *T. forsythia* UB4 as well, where a unique peak at *m*/*z =* 654.3 could be detected in the cellular pool of nucleotide-activated sugars of both the *T. forsythia* UB4 wild-type and the UB4 Δ*TFUB4_00887* mutant (Figure [4](#cwx019F4){ref-type="fig"}B). This compound eluted just after CMP-Pse5Am7Gra on a porous graphitized carbon (PGC) column and showed the typical *m*/*z =* 322.0 fragment peak of CMP upon collision induced decay ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}), supporting its identity as a CMP-activated Leg derivative. In analogy to the data presented for *T. forsythia* ATCC 43037 (Figure [4](#cwx019F4){ref-type="fig"}A), the said *m*/*z =* 654.3 peak was absent in a UB4 Δ*legC* mutant which is deficient in CMP-Leg biosynthesis ([@cwx019C10]).

*Tannerella forsythia* strains cross-complemented with the nonnative putative nonulosonic acid derivative transferase remain without nonulosonic acid derivative attachment to the protein *O*-glycan {#cwx019s2d}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Considering the high amino acid sequence similarity (81%) of the two candidate transferases under investigation and the stereoisomeric character of the Pse and Leg backbones, cross-complementation experiments of the *T. forsythia* mutants with proven deficiency in the respective nonulosonic acid derivative in the *O*-glycan structure (Figure [3](#cwx019F3){ref-type="fig"}A and B) with the nonnative putative nonulosonic derivative transferase were performed. Specifically, the *T. forsythia* ATCC 43037 Δ*Tanf_01245* mutant was complemented with the *TFUB4_00887* gene, and vice versa, i.e., the UB4 Δ*TFUB4_00887* mutant was complemented with the ATCC derived *Tanf_01245* gene ([Supplementary Figures S2A and S3A](#sup1){ref-type="supplementary-material"}).

The cross-complemented strains *T. forsythia* ATCC 43037 Δ*Tanf_01245*^*+TFUB4_00887*^ and *T. forsythia* UB4 Δ*TFUB4_00887*^+*Tanf_01245*^ were first analyzed on CBB-stained SDS-PAGE gels and Western immunoblots targeted at the TfsA and TfsB S-layer glycoproteins. However, neither of the cross-complemented strains showed the up-shift of the S-layer glycoproteins to the wild-type level (Figure [2](#cwx019F2){ref-type="fig"}). This result was confirmed by mass spectrometric analyses, in which both cross-complemented strains exhibited an *m*/*z* signal of 1523.3 \[M + H\]^+^ as maximum glycan mass. This mass was clearly indicative of the presence of *T. forsythia O*-glycans without the terminal nonulosonic derivative and without a methyl group (Figure [3](#cwx019F3){ref-type="fig"}).

In conclusion, these data suggest that the candidate transferases Tanf_01245 and TFUB4_00887 have high stringency for their CMP-substrate.

Discussion {#cwx019s3}
==========

Pathogenic bacteria frequently decorate their cell envelope with nonulosonic acids ([@cwx019C26]; [@cwx019C31]). Major roles have been attributed to these sugar acids in biology and disease, including involvement in bacterial biofilm formation and motility. For instance, Leg glycan modification in *C. jejuni* was shown to be important for colonization of chickens ([@cwx019C17]), nonulosonic acid modification of the LPS of *Vibrio vulnificus* was shown to promote survival in the host bloodstream ([@cwx019C27]), and there are various reports on the requirement of Pse modification for flagellar filament assembly in *Campylobacter* strains ([@cwx019C12]) and in *Treponema denticola* ([@cwx019C23]). Further, it is speculated that pathogens may use nonulosonic acids other than sialic acids in molecular mimicry ([@cwx019C64]), with a direct interaction between Pse on *C. jejuni* flagella and Siglec-10 receptor having been experimentally demonstrated ([@cwx019C53]).

Biosynthetic pathways for Sia, Pse and Leg can be predicted with a wide distribution among archaea and bacteria, including the bacterial phylum *Bacteroidetes* to which *T. forsythia* is affiliated ([@cwx019C26]). While the biosynthetic pathways leading from UDP-GlcNAc to CMP-Pse and that from GDP-GlcNAc to CMP-Leg have been elucidated in detail in different bacteria ([@cwx019C45], [@cwx019C46]), and, recently, also in *T. forsythia* ([@cwx019C10]), it is still unknown how the indispensable subsequent transfer step of Pse and Leg or derivatives thereof from the activated state onto an acceptor saccharide or polypeptide is elaborated. Considering the increasing documentation of the occurrence of Pse and Leg in pathogens, it is surprising that reports on putative Pse- or Leg-transferases in the literature are scarce ([@cwx019C36]; [@cwx019C69]).

This study was designed to shed light on putative nonulosonic acid derivative transferases encoded in the genome of different strains of *T. forsythia*, a periodontal pathogen which was shown to decorate its cell surface with either a Pse or a Leg derivative present as a terminal residue on otherwise structurally identical and abundant S-layer glycoprotein *O*-glycans ([@cwx019C38]; [@cwx019C10]). Specifically, we investigated the candidate CMP-Pse5Am7Gra:ManNAcA transferase Tanf_01245 from *T. forsythia* ATCC 43037 and the candidate CMP-Leg derivative:ManNAcA transferase TFUB4_00887 from *T. forsythia* UB4 (which is also present in *T. forsythia* FDC 92A2) (for glycan structure, see [@cwx019C10]). The identification of biosynthetic pathway genes for either CMP-Pse or CMP-Leg in conjunction with a gene encoding a putative nonulosonic derivative transferase in immediate vicinity on the genome of different strains of the same bacterium is interesting from an evolutionary point of view, since it raises the question about what has shaped the genome content of different *T. forsythia* strains and how this may contribute to the pathogenesis of periodontal diseases.

The high similarity of the two candidate transferases at primary sequence level was not unexpected, since their nonulosonic acid substrates are stereoisomers, albeit with different noncarbohydrate modifications (5Am7Gra in Pse vs. calculated AcGc in Leg). A multiple sequence alignment revealed an identical, 245-amino acid comprising, C-terminal protein region of Tanf_01245 and TFUB4_00887, and a GT-B or TagB superfamily domain (*vide infra*) is predicted (Figure [1](#cwx019F1){ref-type="fig"}). The prediction of two domains on the amino acid sequence level is in agreement with the two-domain presentation of known 3D structures from crystallized GTs with both GT-A and GT-B folds ([@cwx019C2]; [@cwx019C25]). A membrane associated third-fold family has been identified based on the crystal structure and kinetic data from an α-2,3/2,8-sialyltransferase (CstII) in *C. jejuni* ([@cwx019C5]). In agreement with the experimental evidence provided in the present study, bioinformatic analysis predicts a GT-fold for the putative *T. forsythia* nonulosonic derivative transferases. However, it cannot be ruled out that a novel GT-fold might be involved in nonulosonic acid transfer, which makes these enzymes exciting objects to study.

Interestingly, a DXD motif as well as a D/E-D/E-G and HP motif, common to bacterial sialyltransferases, were identified in all investigated nonulosonic acid transferases (Figure [1](#cwx019F1){ref-type="fig"}A). Glycosyltransferases from the A-type family share this common DXD motif, which interacts primarily with the phosphate group of the respective nucleotide donor ([@cwx019C2]; [@cwx019C25]). Yet, a DXD motif is only a decent indication of a GT, since it is not necessarily present in this class of enzymes as exemplified by a CMP-Sia utilizing enzyme from *C. jejuni* ([@cwx019C5]). A significant support for a transferase function of both enzymes, Tanf_01245 and TFUB4_00887, is derived from homology searches predicting a TagB superfamily domain or a GT B-type superfamily domain located at the rather N-terminal part of the proteins (Figure [1](#cwx019F1){ref-type="fig"}B). TagB is a glycerophosphate transferase from the wall teichoic acid biosynthesis in *B. subtilis* 168 where it catalyzes the transfer of a single phosphoglycerol unit from CDP-glycerol onto the C-4 hydroxyl of a ManNAc residue ([@cwx019C54]). Even though glycerol and nonulosonic acids are clearly different substrates, two remarkable analogies are evident; first, the ManNAc residue from the teichoic acid backbone has the same basic structure as the ManNAcA residue, which is the acceptor saccharide for the nonulosonic acids in *T. forsythia O*-glycan biosynthesis, and secondly, an 1,4-linkage as formed upon TagB catalysis is also implemented in the terminal transfer of the Pse and Leg derivative onto the ManNAcA residue within the known *O*-glycan structure (for glycan structure, see [@cwx019C10]).

Thus, it is conceivable to assume that the conserved C-terminal protein region of Tanf_01245 and TFUB4_00887, encompassing the DXD, the D/E-D/E-G and HP motifs, is involved in the binding of the CMP activator of both the Pse and Leg derivative, while the TagB domain might specifically bind the nonulosonic acid portion of CMP-Pse5Am7Gra and the CMP-Leg derivative, respectively (Figure [1](#cwx019F1){ref-type="fig"}A).

Experimentally, we have successfully proven the requirement of Tanf_01245 from *T. forsythia* ATCC 43037 and TFUB4_00887 from *T. forsythia* UB4 for the full saccharide assembly of the *T. forsythia* protein *O*-glycans. Deletion of *Tanf_01245* and *TFUB4_00887*, respectively, resulted in a Pse5Am7Gra and Leg derivative deficient phenotype as revealed by LC-ESI-MS of β-eliminated *O*-glycans from TfsB (Figure [3](#cwx019F3){ref-type="fig"}) and TfsA (not shown). To exclude that polar effects would cause the loss of the respective nonulosonic acid, we showed that reconstituted strains regained the Pse5Am7Gra and Leg derivative transfer activity yielding the native dekasaccharide form of the glycan (Figure [3](#cwx019F3){ref-type="fig"}).

Since the biosynthetic enzymes for the noncarbohydrate modifications on the *T. forsythia* nonulosonic acids are currently unknown, it was important to demonstrate that these have not been unintentionally targeted in the deletion mutants and that, consequently, indeed the fully modified sugar acid would be available in CMP-activated form. For instance, deletion of genes involved in the biosynthesis of the acetamidino group in *Methanococcus maripaludis* resulted in flagellins with a truncated glycan that did not only miss the acetamidino group present on an inner sugar (a modified ManNAc residue) but also the terminal sugar of the flagellin glycan ([@cwx019C19]). This indicates that the loss of noncarbohydrate substituents within a glycan might influence down-stream enzymes. ESI-IT-MS analyses of the cellular pools of nucleotide-activated sugars from the Δ*Tanf_01245* and Δ*TFUB4_00887* mutant strains in comparison to the ATCC 43037 and UB4 parent strains demonstrated the presence of the mature Pse and Leg derivative, respectively, at *m/z =* 683.2 in both ATCC 43037 samples and *m/z =* 654.3 in both UB4 samples (Figure [4](#cwx019F4){ref-type="fig"}). Further, the presence of CMP was proven by the appearance of a typical *m*/*z =* 322.0 fragment in the MS/MS spectrum ([Supplementary, Figure S1](#sup1){ref-type="supplementary-material"}), which was especially important for the *T. forsythia* UB4 strain, as the structure of its Leg derivative has not been fully elucidated so far.

To learn about the substrate specificity of the predicted *T. forsythia* Pse5Am7Gra and Leg derivative transferase, cross-complementation experiments were performed. Complementation of *T. forsythia* ATCC 43037 Δ*Tanf_01245* and *T. forsythia* UB4 Δ*TFUB4_00887* with the nonnative enzyme could not restore the native *O*-glycan phenotype (Figure [3](#cwx019F3){ref-type="fig"}), despite identity of the underlying *O*-glycan structure. Considering that even cross-glycosylation experiments between different species of the *Bacteroidetes*, namely between *T. forsythia* ATCC 43037 and *Bacteroides fragilis* have been successful ([@cwx019C39]), it is conceivable to assume that Tanf_01245 from *T. forsythia* ATCC 43037 and TFUB4_00887 from *T. forsythia* UB4 possess high stringency for the CMP-activated nonulosonic acid substrate. Whether stringency relates to the stereoisomery or the modifications of the nonulosonic acids or both remains to be investigated.

While we have provided strong evidence of the discovery of two new nonulosonic acid transferases in different strains of the periodontal pathogen *T. forsythia*, the development of a dedicated in vitro assay to unequivocally prove the enzymatic activity of the investigated *T. forsythia* enzymes is currently under way. Given the power of current glycoengineering approaches the present study may contribute to the design of novel nonulosonic acid-based glycoconjugates of potential therapeutic relevance in the future.

Materials and methods {#cwx019s4}
=====================

Bacterial strains and growth conditions {#cwx019s4a}
---------------------------------------

*Tannerella forsythia* ATCC 43037 type-strain (American Type Culture Collection---ATCC, Manassas, VA) ([@cwx019C11]) and *T. forsythia* UB4 (clinical isolate kindly provided by Dr. Ashu Sharma, State University of New York at Buffalo, NY) and defined mutants (Table [I](#cwx019TB1){ref-type="table"}) were grown anaerobically as described previously ([@cwx019C58]). Briefly, brain heart infusion (BHI) liquid medium (Oxoid, Basingstoke, UK) with a concentration of 37.0 g/L was supplemented with 10.0 g/L of yeast extract (Oxoid), 1.0 g/L [l]{.smallcaps}-cysteine (Sigma, Vienna, Austria), 5.0 µg/mL hemin (Sigma), 2.0 µg/mL menadione (Sigma), 20 µg/mL *N-*acetylmuramic acid (Carbosynth, Compton, UK) and 5% (v/v) horse serum (Thermo Fisher Scientific, Vienna, Austria). For cultivation of *T. forsythia* wild-type and mutant strains on BHI agar plates (0.8%, w/v), incubation was performed in anaerobic jars (AnaeroJar; Oxoid) at 37°C. Media were supplemented with 50 µg/mL gentamycin, 5 µg/mL erythromycin or 10 µg/mL chloramphenicol (Cat), when appropriate. Table I.Bacterial strains and plasmids used in this studyStrain or plasmidGenotype and use or descriptionSource or reference*Escherichia coli* strain DH5αF^--^ Φ80*lac*ZΔM15 Δ(*lac*ZYA-*arg*F) U169 *rec*A1 *end*A1 *hsd*R17 (rK--, mK+) *pho*A *sup*E44 λ-- *thi*-1 *gyr*A96 *rel*A1; cloning strainInvitrogen, Austria*Tannerella forsythia* strains ATCC 43037Type strain, wild-typeATCC; [@cwx019C11] ATCC 43037 Δ*Tanf_01245*Δ*Tanf_01245*::*ermF*; knock-out strain of *Tanf_01245*This work ATCC 43037 Δ*Tanf_01245*^*+*^Δ*Tanf_01245*::*Tanf_01245 cat*; reconstituted knock-out strainThis work ATCC 43037 Δ*Tanf_01245*^*+TFUB4_00887*^Δ*Tanf_01245*:: *TFUB4_00887cat*; cross-complemented knock-out strainThis work ATCC 43037 Δ*pseC*Δ*pseC*::*ermF*; knock-out strain of *Tanf_01190*[@cwx019C10] UB4Clinical isolate; wild-type strain[@cwx019C52] UB4 Δ*TFUB4_00887*Δ*TFUB4_00887*::*ermF*; knock-out strain of *TFUB4_00887*This work UB4 Δ*TFUB4_00887*^*+*^Δ*TFUB4_00887*::*cat*; reconstituted knock-out strainThis work UB4 Δ*TFUB4_00887*^*+Tanf_01245*^Δ*TFUB4_00887*::*Tanf_01245 cat*; cross-complemented knock-out strainThis work UB4 Δ*legC*Δ*legC*::*ermF*; knock-out strain of *TFUB4_00900*[@cwx019C10] FDC 92A2Wild-type strainATCC; [@cwx019C55]Plasmids pJET1.2/bluntCloning vector; *amp*^*R*^Thermo Scientific, Austria pJET/ΔTF0955koVector for amplification of the erythromycin resistance gene[@cwx019C58] pEXALVVector for amplification of the Cat resistance gene[@cwx019C70] pJET1.2/Δ*Tanf_01245Tanf_01245* knock-out cassette; *amp*^*R*^*ermF*^*R*^This work pJET1.2/Δ*Tanf_01245*^*+*^Cassette for reconstitution of Δ*Tanf_01245*; *amp*^*R*^*cat*^*R*^This work pJET1.2/Δ*Tanf_01245*^*+TFUB4_00887*^Cassette for cross-complementation of Δ*Tanf_01245* with *TFUB4_00887*; *amp*^*R*^*cat*^*R*^This work pJET1.2/Δ*TFUB4_00887TFUB4_00887* knock-out cassette; *amp*^*R*^*ermF*^*R*^This work pJET1.2/Δ*TFUB4_00887*^*+*^Cassette for reconstitution of Δ*TFUB4_00887*; *amp*^*R*^*cat*^*R*^This work pJET1.2/Δ*TFUB4_00887*^*+Tanf_01245*^Cassette for cross-complementation of Δ*TFUB4_00887* with *Tanf_01245*; *amp*^*R*^*cat*^*R*^This work

*Escherichia coli* strains (Table [I](#cwx019TB1){ref-type="table"}) were grown under standard conditions in lysogeny broth (LB) medium supplemented with 100 µg/mL ampicillin, when appropriate.

Construction of knock-out strains deficient in pseudaminic or legionaminic acid transferase activity {#cwx019s4b}
----------------------------------------------------------------------------------------------------

Vectors were constructed to knock-out candidate genes for a Pse5Am7Gra transferase in *T. forsythia* ATCC 43037 (gene *Tanf_01245*) and for a Leg derivative in *T. forsythia* UB4 (gene *TFUB4_00887*) (Table [I](#cwx019TB1){ref-type="table"}). A detailed description of the cloning procedure and the transformation of knock-out cassettes into *T. forsythia* is published elsewhere ([@cwx019C58]). For PCR amplifications, Phusion High-Fidelity DNA polymerase (Thermo Fisher Scientific) was used according to the manufacturer\'s instructions. Oligonucleotides (Thermo Fisher Scientific) used in this study are listed in Table [II](#cwx019TB2){ref-type="table"}. Extraction of genomic DNA was performed according to a published protocol ([@cwx019C4]). Table II.Oligonucleotide primers used for PCR amplification reactionsPrimersSequence (5′--3′)1^[a](#cwx019tfn1){ref-type="fn"}^GGTACCCCCGATAGCTTCCGCTATTGC2CTACGAAGGATGAAATTTTTCAGGG3^[a](#cwx019tfn1){ref-type="fn"}^GCAATAGCGGAAGCTATCGGGGGTACC4CCCTGAAAAATTTCATCCTTCGTAG48GTCAGATAGGCCTAATGACTGGC76TTATAAAAGCCAGTCATTAGGCCTATCTGAC77^[b](#cwx019tfn2){ref-type="fn"}^aatca[GCATGC GGTACC]{.ul}TTATAAAAGCCAGTCATTAGGCCTATCTGAC118ATGGCTACAATGGTCTGTAATTATCTTC119TTATATTACTGTTATTGTTCGTAGATCC120CCATGATAATCTCGACTTCGG121**GCAATAGCGGAAGCTATCGGGGGTACC**ATTCCTATCTCTTGAAGGATAGG122**CCCTGAAAAATTTCATCCTTCGTAG**GTATAGAGGTACAATGGATATAGGGC123GCACCCATTTATCTAAATAATCTTC124GGCCCTCAACCTTTTCTGGC125CCTATCCTTTAGGTATCTATATG126^[b](#cwx019tfn2){ref-type="fn"}^**CGAACAATAACAGTAATATAA**[TGTACA]{.ul}ATGAACTTTAATAAAATTGATTTAGAC127aatca[CATATGGGTACC]{.ul}TTATAAAAGCCAGTCATTAGGCCTATCTGAC128aatca[GGTACC]{.ul}GTATAGAGGTACAATGGATATAGGGC130**CCAATTGTCTAAATCAATTTTATTAAAGTTCAT**[TGTACA]{.ul}TTATATTACTGTTATTGTTCGTAGATCC133aatca[TGTACA]{.ul}TTATATTACTGTTATTGTTCGTAGATCCTC134aatca[CTCGAG]{.ul}CCATGATAATCTCGACTTCGG140aatca[CATATG]{.ul}GCACCCATTTATCTAAATAATCTTC152**CTAAATTTCTTTCATAATAATTCTTTGTATA**ATGATTGATGTTTTAAATTTAGAATGGACC153**GGTCCATTCTAAATTTAAAACATCAATCAT**TATACAAAGAATTATTATGAAAGAAATTTAG460^[c](#cwx019tfn3){ref-type="fn"}^ATGACAAAAAAGAAATTGCCCGTTCGTTTTAC461^[c](#cwx019tfn3){ref-type="fn"}^CTACGAAGGATGAAATTTTTCAGGGACAAC474^[d](#cwx019tfn4){ref-type="fn"}^**CGGGCAATTTCTTTTTTGTCAT**TTCTTAATGTAATCTAAGTCCAACCG475^[d](#cwx019tfn4){ref-type="fn"}^TTGTAGCAGAACTATCAGCCAATCAC476^[d](#cwx019tfn4){ref-type="fn"}^**GTTGTCCCTGAAAAATTTCATCCTTCGTAG**GTATAGAGGTACAATGGATATAG477^[d](#cwx019tfn4){ref-type="fn"}^CCCAGACTCTTCTTTAACAAGAAACC512TGCAGGCTGCAATTGATTCC513GATCCCACGTGAAAGCAAATA524GTAAAACGAACGGGCAATTTCTTTTTTGTCAT525CCCTGAAAAATTTCATCCTTCGTAG530CGTATGATATTTGCAGTCTTG531GTAATAACCATATCTGCCTCTGGAAC540CAACAATTGTAGCAGAACTATCAGCC541aatca[GGTACC]{.ul}TATAAGTATAGAGGTACAATGGATATAGG542aatca[GCATGC]{.ul}GGTATCTATATGAAGTACGCACC543ctga[CTCGAG]{.ul}CAACAATTGTAGCAGAACTATC565CTAAATCAATTTTATTAAAGTTCAT575**TCTAAATTAAGAATATCCAT**TTCTTAATGTAATCTAAGTCCAACCGCATTCC576**GACTTAGATTACATTAAGAA**ATGGATATTCTTAATTTAGAATGGACTTCCNucleotides used for overlap-extension PCRs are written in bold, artificial restriction sites are underscored. Lowercase letters indicate artificially introduced bases to improve restriction enzyme digestion.[^4][^5][^6][^7]

The knock-out vectors for the construction of a *T. forsythia* ATCC 43037 Δ*Tanf_01245* and a *T. forsythia* UB4 Δ*TFUB4_00887* mutant consisted of approximately 1-kbp up- and down-stream homology regions and an erythromycin resistance marker (*ermF*) cloned in between. Primer pairs 474/475 and 476/477, respectively, were used to amplify the up- and down-stream homology regions from genomic DNA of *T. forsythia* ATCC 43037, and primer pairs 120/121 and 122/123 were used to amplify those from genomic DNA of *T. forsythia* UB4. The antibiotic resistance gene *ermF* (805 bp) was amplified from pJET/TF0955ko ([@cwx019C58]), either without the promotor region using primers 460 and 461 or including the native promotor using primers 1 and 2. Subsequently, each knock-out cassette was blunt-end cloned into the cloning vector pJET1.2, creating the final knock-out vectors pJET1.2/Δ*Tanf_01245* and pJET1.2/Δ*TFUB4_00887*. Transformed and viable clones on selective plates containing erythromycin were further tested for correct integration of the knock-out cassette by screening PCR ([Supplementary Figures S2 and S3](#sup1){ref-type="supplementary-material"}).

To reconstitute the transferase function in the *T. forsythia* ATCC 43037 Δ*Tanf_01245* and *T. forsythia* UB4 Δ*TFUB4_00887*mutants, the genes of interest were re-integrated by homologous recombination including *cat* as an alternate resistance gene for selection purposes ([Supplementary Figures S2 and S3](#sup1){ref-type="supplementary-material"}). The up-stream region, including the approximately 1-kbp up-stream homology region and the 1338-bp *Tanf_01245* gene, was amplified with primer pair 540/130 from genomic DNA of *T. forsythia* ATCC 43037. The 650-bp *cat* gene (without the native promotor) was amplified using pEXALV as a template ([@cwx019C70]) and primers 126/77 prior to addition to the up-stream region by way of overlap-extension PCR. The construct was blunt-end ligated into the cloning vector pJET1.2. The approximately 1-kbp down-stream homology region (541/542) was cloned into the above mentioned pJET1.2 construct using the restriction sites *Kpn*I and *Sph*I, assembling the final construct pJET1.2/Δ*Tanf_01245*^+^. After control digestion (not shown), electrocompetent *T. forsythia* Δ*Tanf_01245* cells were transformed with the final construct.

Analogously, up-stream and *TFUB4_00887* gene primers 120/130, *cat* primers 126/127 and down-stream primers 128/140 (with *Kpn*I and *Nde*I restriction sites) were used to construct the reconstitution cassette pJET1.2/Δ*TFUB4_00887*^+^. Subsequent steps were performed as described for the *Tanf_01245*-based construct, yielding the final construct pJET1.2/Δ*TFUB4_00887*^+^.

Cross-complementation of nonulosonic acid transferase deficient mutants {#cwx019s4c}
-----------------------------------------------------------------------

Based on the reconstitution cassette pJET1.2/Δ*Tanf_01245*^+^, a cross-complementation cassette was constructed by replacing the native gene *Tanf_01245* with *TFUB4_00887*. The native up-stream region was amplified with primers 543 (including an *Xho*I restriction site) and 575. The UB4 *TFUB4_00887* gene was amplified using primer pair 576/133(*BsrG*I) and cloned to the up-stream region by overlap-extension-PCR. Via the restriction sites *Xho*I and *BsrG*I, the native gene was replaced by the nonnative gene, assembling the final cross-complementation cassette pJET1.2/Δ*Tanf_01245*^+*TFUB4_00887*^.

Analogously, the cross-complementation cassette pJET1.2/Δ*TFUB4_00887*^+*Tanf_01245*^ for the UB4 strain was constructed. Briefly, primers 134(*Xho*I)/153 were used for the amplification of the up-stream homology region and 152/133(*BsrG*I) for the amplification of the *Tanf_01245* gene. Clones were tested for correct integration on genomic level after transformation and selection ([Supplementary Figures S2 and S3](#sup1){ref-type="supplementary-material"}).

SDS-PAGE and Western immunoblotting {#cwx019s4d}
-----------------------------------

SDS-PAGE gels (7.5%) were prepared according to a standard protocol ([@cwx019C24]). Crude cell extracts of *T. forsythia* ATCC 43037, UB4 and defined mutants thereof were run in a Mini Protean electrophoresis apparatus (Bio-Rad, Vienna, Austria) and proteins were visualized with colloidal CBB R-250. For Western immunoblot analyses, proteins were transferred onto a polyvinylidene difluoride membrane (Bio-Rad) using a Mini Trans-Blot Cell (Bio-Rad). Polyclonal antisera raised in rabbits against the recombinant S-layer proteins TfsA (α-TfsA) and TfsB (α-TfsB) ([@cwx019C48]) were used as primary antibodies followed by a monoclonal goat anti-rabbit secondary antibody labeled with IRDye 800CW (LI-COR Biosciences, Lincoln, NE). S-layer protein bands were visualized at 800 nm using an Odyssey Infrared Imaging System (LI-COR Biosciences).

S-layer *O*-glycan preparation and liquid chromatography ESI-IT-MS {#cwx019s4e}
------------------------------------------------------------------

The preparation and release of *O*-glycans from the glycosylated S-layer proteins TfsA and TfsB by in-gel reductive β-elimination was performed as described previously ([@cwx019C38]; [@cwx019C58]). Removal of excess salt via PGC cartridges was performed according to published protocols ([@cwx019C35]; [@cwx019C51]) and the final purification of borohydride reduced *O*-glycans prior to ESI-IT-MS analyses was completed using preparative PGC-HPLC ([@cwx019C38]). The glycan mixture was analyzed using a Dionex Ultimate 3000 system directly linked to an ion trap instrument (amaZon speed EDT, Bruker, Germany) equipped with the standard ESI source in the positive ion, DDA mode (= switching to MSMS mode for eluting peaks). MS-scans were recorded (range, 450-1650 *m*/*z*; icc target was set to 100,000; maximum accumulation time, 200 ms) and the highest peaks were selected for fragmentation. Instrument calibration was performed using ESIcalibration mixture (Agilent, Vienna, Austria). For separation of the glycans, a Thermo Hypercarb separation column (5 µm particle size; 100 × 0.360 mm) was used. A gradient from 99% solvent A and 1% solvent B (solvent A, 65 mM ammoniumformate buffer (pH 3.0); B, 100% acetonitrile) to 21% B in 20 min was applied, followed by a 10-min gradient from 21% B to 50% B, at a flow rate of 6 µl/min. Data were evaluated using the DataAnalysis 4.0 software (Bruker).

Extraction, purification and analysis of nucleotide-activated sugars {#cwx019s4f}
--------------------------------------------------------------------

Cellular pools of nucleotide-activated sugars were extracted and purified as described before ([@cwx019C38]). Briefly, 2 mL of bacterial solution was harvested by centrifugation, washed in phosphate-buffered saline and lysed by ultrasonication in 62 mM sodium fluoride buffer before loading onto a Hypersep Hypercarb 10 mg column (Thermo Scientific, Vienna, Austria). Elution of GDP-, UDP- and CMP-activated sugars was done with 50% acetonitrile in 50 mM ammoniumformate buffer pH 9.0. The glycan mixture was analyzed using a Dionex Ultimate 3000 system directly linked to an ion trap instrument (amaZon speed EDT) equipped with the standard ESI source in the negative ion, DDA mode (= switching to MSMS mode for eluting peaks). MS-scans were recorded (range, 200--900; *m*/*z*; icc target was set to 15,000; maximum accumulation time, 200 ms; target mass was set to 600 *m/z*) and the five highest peaks were selected for fragmentation. Instrument calibration was performed using ESIcalibration mixture (Agilent). For separation of the analytes, a Thermo Hypercarb separation column (5 µm particle size, 100 × 0.360 mm) was used. A gradient from 99% solvent A and 1% solvent B (solvent A, 0.3% formic acid adjusted to pH 9.0 with ammonia solution, B, 100% acetonitrile) to 25% B in 20 min was applied, followed by a 10-min gradient from 25% B to 50% B, at a flow rate of 6 µL/min. Data were evaluated using the DataAnalysis 4.0 software (Bruker).
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